ESPOIR BE VELVET COVER CUSHION BROAD SPECTRUM SPF42 SUNSCREEN

Manufacturer
ESPOIR Corporation
Effective date
2026-06-21
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
monthly-update
Hydrated at
2026-07-17 21:35:11

Label at a glance#

ProductESPOIR BE VELVET COVER CUSHION
Active ingredientTITANIUM DIOXIDE, HOMOSALATE
Label structure1 sections

Label contents#

Full prescribing information#

ESPOIR BE VELVET COVER CUSHION BROAD SPECTRUM SPF42 SUNSCREEN

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Drug Facts

Active ingredients

OTC - ACTIVE INGREDIENT SECTION

Homosalate 6.0%

Titanium dioxide 4.3%

Purpose

OTC - PURPOSE SECTION

Sunscreen

Uses

INDICATIONS & USAGE SECTION

■ Helps prevent sunburn.

■ If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun.

Warnings

WARNINGS SECTION

For external use only

Do not use

OTC - DO NOT USE SECTION

on damaged or broken skin.

When using this product

OTC - WHEN USING SECTION

keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor if

OTC - STOP USE SECTION

rash occurs.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

■ Apply liberally 15 minutes before sun exposure.

■ Reapply at least every 2 hours.

■ Use a water resistant sunscreen if swimming or sweating.

■ Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:

■ limit time in the sun, especially from 10 a.m.- 2 p.m.

■ wear long-sleeved shirts, pants, hats, and sunglasses.

■ Children under 6 months of age: Ask a doctor.

Other information

OTHER SAFETY INFORMATION

■ Protect the product in this container from excessive heat and direct sun.

Inactive ingredients

INACTIVE INGREDIENT SECTION

#13 PORCELAIN

WATER, METHYL TRIMETHICONE, DIMETHICONE, BUTYLENE GLYCOL, LAURYL POLYGLYCERYL-3 POLYDIMETHYLSILOXYETHYL DIMETHICONE, SILICA, ISODODECANE, DIISOPROPYL SEBACATE, ACRYLATES/POLYTRIMETHYLSILOXYMETHACRYLATE COPOLYMER, TRISILOXANE, GLYCERIN, SODIUM CHLORIDE, VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER, VP/HEXADECENE COPOLYMER, 1,2-HEXANEDIOL, ALCOHOL DENAT., MAGNESIUM/POTASSIUM/SILICON/FLUORIDE/HYDROXIDE/OXIDE, DIMETHICONE CROSSPOLYMER, ALUMINUM HYDROXIDE, ACRYLATES/DIMETHICONE COPOLYMER, DISTEARDIMONIUM HECTORITE, TRIHYDROXYSTEARIN, TRIETHOXYCAPRYLYLSILANE, STEARIC ACID, CAPRYLYL GLYCOL, POLYSILICONE-11, FRAGRANCE / PARFUM, GLYCERYL CAPRYLATE, ORYZA SATIVA (RICE) BRAN WAX, GLYCERYL UNDECYL DIMETHICONE, SODIUM COCOYL GLUTAMATE, HYALURONIC ACID, LAUROYL LYSINE, ARGININE, TOCOPHEROL, HYDROLYZED VEGETABLE PROTEIN, [+/-(MAY CONTAIN): TITANIUM DIOXIDE (CI 77891), IRON OXIDES (CI 77492, CI 77491, CI 77499)]

Questions?

OTC - QUESTIONS SECTION

Visit www.espoir.com or
ESPOIRMALL@ESPOIR.COM

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Outer package_cartonOuter package_cartonOuter package_carton labelOuter package_carton label

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 39 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84469-70184469-701-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 37 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ESPOIR BE VELVET COVER CUSHIONHOMOSALATE, TITANIUM DIOXIDEESPOIR Corporation54ce2420-4ac0-eb51-e063-6294a90a2de92026-06-21WarningsExact identifier
ndc (package): 84469-701-01
ndc (product): 84469-701
ndc11 (package): 84469070101
spl id: 54ce2420-4ac1-eb51-e063-6294a90a2de9
spl set id: 54ce2420-4ac0-eb51-e063-6294a90a2de9

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.